Regional cerebral blood flow in patients with systemic lupus erythematosus

Journal of Neuroimaging

Volumn 9, Issue 3, 1999, Pages 160-164

  Shen, Yeh You ^a   Kao, Chia Hung ^b   Ho, Yung Jen ^c   Lee, Jong Kang ^d  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c JEN AI HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Regional cerebral blood flow; Systemic lupus erythematosus; Tc 99m HMPAO

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; ARTICLE; BASAL GANGLION; BRAIN BLOOD FLOW; BRAIN PERFUSION; CEREBELLUM; DIAGNOSTIC VALUE; FEMALE; FRONTAL LOBE; HUMAN; MAJOR CLINICAL STUDY; NEUROPATHOLOGY; OCCIPITAL LOBE; PARIETAL LOBE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS; THALAMUS; THREE DIMENSIONAL IMAGING; BRAIN REGION; CONTROLLED STUDY; FILTER; MENTAL DISEASE; RANDOMIZED CONTROLLED TRIAL;

EID: 0032765032     PISSN: 10512284     EISSN: None     Source Type: Journal    
DOI: 10.1111/jon199993160     Document Type: Article

References (39)

1. Van Dam AP. Diagnosis and pathogenesis of CNS lupus. Rheumatol Int 1991;11:1-11
2. Hughes RAC. Pathogenesis of neurological involvement in SLE. Lancet 1994;343:580-581
3. Ellis SG, Verity MA. The central nervous system involvement in systemic lupus erythematosus. A review of neuropathologic findings in 57 cases, 1955-1977. Semin Arthritis Rheum 1979;8:212-221
4. Klippel JH, Zvaifler NJ. Neuropsychiatric abnormalities in systemic lupus erythematosus: an overview. Semin Arthritis Rheum 1986;15:185-199
5. Carbott RM. Denburg SD, Denburg JA. Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis 1986;174:357-364
6. Gaylis NB, Altman RD, Ostrov S, et al. The selective value of computed tomography of the brain in the cerebritis due to SLE. J Rheumatol 1982;9:850-854
7. O'Connor P. Diagnosis of central nervous system lupus. Can J Neurol Sci 1988;15:257-260
8. Nossent JC, Hovestadt A, Schonfeld DHW, Swaak AJG. Single-photon-emission computed tomography of the brain in the evaluation of cerebral lupus. Arthritis Rheum 1991; 34:1397-1403
9. Vermess M, Bernstein RM, Bydder GM, Steiner RE, Young IR, Hughes GRV. Nuclear magnetic resonance imaging of the brain in systemic lupus erythematosus. J Comput Assist Tomogr 1983;7:461-467
10. Stoppe G, Wildhagen K, Seidel JW. et al. Positron emission tomography in neuropsychiatric lupus erythematosus. Neurology 1990;40:304-308
11. Carbotte RM, Denburg SD, Denburg JA, Nahmias C, Garnett ES. Fluctuating cognitive abnormalities and cerebral glucose metabolism in neuropsychiatrie systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 1992;55: 1054-1059
12. Perani D, di Piero V, Vallar G, et al. Technetium-99m HMPAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. J Nucl Med 1988;29:1507-1514
13. Stefan H, Kuhnen C, Biersack HJ, et al. Initial experience with 99mTc hexamethylpropylene amine oxime (HMPAO) single photon emission computed tomography (SPECT) in patients with focal epilepsy. Epilepsy Res 1987;1:134-138
14. Isshi K, Hirohata S, Hashimoto T, Miyashita H. Systemic lupus erythematosus presenting with diffuse low density lesions in the cerebral white matter on computed axial tomography scans: its implication in the pathogenesis of diffuse central nervous system lupus. J Rheumatol 1994;21: 1758-1762
15. Rubbert A, Marienhagen J, Pirner K, et al. Single-photon-emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus. Arthritis Rheum 1993;36:1253-1262
16. Kodama K, Okada S, Hino T, et al. Single photon emission computed tomography in systemic lupus erythematosus with psychiatric symptoms. J Neurol Neurosurg Psychiatry 1995;58:307-311
17. Emmi L, Bramati M, Cristofaro MTR, et al. MRI and SPECT investigations of the CNS in SLE patients. Clin Exp Rheumatol 1993;11:13-20
18. Kao CH, Lan JL, ChangLai SP, Chieng PU. Technetium-99m-HMPAO brain SPECT in Sjögren syndrome. J Nucl Med 1998;39:773-777
19. Levin JM, Holman BL, Medelson JH, et al. Gender differences in cerebral perfusion in cocaine abuse: technetium-99m-HMPAO SPECT study of drug-abusing women. J Nucl Med 1994;35:1902-1909
20. Jones K, Johnson KA, Becker JA, Spiers PA, Albert MS, Holman BL. Use of singular value decomposition to characterize age and gender differences in SPECT cerebral perfusion. J Nucl Med 1998;39:965-973
21. Lin WY, Wang SJ, Yen TC, Lan JL. Technetium-99m-HMPAO brain SPECT in systemic erythematosus with CNS involvement. J Nucl Med 1997;38:1112-1115
22. Szer IS, Miller JI, Rawlings D, Shaham B, Bernstein B. Cerebral perfusion abnormalities in children with central nervous system manifestations of lupus detected by single photon emission computed tomography. J Rheumatol 1993;20:2143-2148
23. Holman BL, Devous MD Sr. Functional brain SPECT: the emergence of a powerful clinical method. J Nucl Med 1992;33:1888-1904
24. Wallis JW, Miller TR. Volume rendering in three-dimensional display of SPECT images. J Nucl Med 1990; 31:1421-1430
25. Denays R, Tondeur M, Noel P, Ham HR. Bilateral cerebral mediofrontal hypoactivity in Tc-99m HMPAO SPECT imaging. Clin Nucl Med 1994;19:873-876
26. Kim HJ, Karp JS, Mozley PD, et al. Stimulating technetium-99m cerebral perfusion studies with a three-dimensional Hoffmann brain phantom: collimator and filter selection in SPECT neuroimaging. Ann Nucl Med 1996;10:153-160
27. Liew SC, Hasegawa BH. Noise, resolution, and sensitivity considerations in the design of a single-slice emission-transmission computed tomographic system. Med Phys 1991;18:1002-1015
28. Keyes JW Jr. Three-dimensional display of SPECT images: advantages and problem [Editorial]. J Nucl Med 1990;31: 1428-1430
29. Wallis JW, Miller TR. Three-dimensional display in nuclear medicine and radiology. J Nucl Med 1991;33:534-546
30. Ishimura J, Fukuchi M. Clinical application of three-dimensional surface display in brain imaging with Tc-99m HMPAO. Clin Nucl Med 1991;16:343-351
31. Shih WJ, Schleenbaker RE, Stipp V, Magoun S, Slevin JT. Surface and volume three dimensional display of Tc-99m HMPAO brain SPECT in stroke patients by a three-headed camera. Clin Nucl Med 1993;18:945-949
32. Devous MD Sr. Comparison of SPECT applications in neurology and psychiatry. J Clin Psychiatry 1992;53:13-19
33. Okuda B, Tachibana H, Kawabata K, Sugita M, Fukuchi M. Three-dimensional surface display with I-123 IMP of slowly progressive apraxia. Clin Nucl Med 1993;18:85-87
34. Carette S, Urowitz M, Grossman H, St. Louis E. Cranial computerized tomography in systemic lupus erythematosus. J Rheumatol 1982;9:855-859
35. Gonzalez-Scarano F, Lisak RP, Bilaniuk LT, Zimmerman RA, Atkins PC, Zweiman B. Cranial computed tomography in the diagnosis of systemic lupus erythematosus. Ann Neurol 1979;5:158-165
36. Kuwabara Y, Ichiya Y, Otsuka M, et al. Differential diagnosis of bilateral parietal abnormalities in I-123 IMP SPECT imaging. Clin Nucl Med 1990;15:893-899
37. DeVolder AG, Goffinet AM, Bol A, Michel C, de-Barsy T, Laterre C. Brain glucose metabolism in postanoxic syndrome: positron emission tomographic study. Arch Neurol 1990;47:197-204
38. Hanly JG, Walsh NMG, Sangalang V. Brain pathology in systemic lupus erythematosus. J Rheumatol 1992;19:732-741
39. Devinsky O, Petito CK, Alonso DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli and thrombotic thrombocytopenia purpura. Ann Neurol 1988;23:380-384